Cargando…
Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells
Although therapeutic effects of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists rosiglitazone and pioglitazone against Cushing's disease have been reported, their effects are still controversial and inconsistent. We therefore examined the effects of a novel PPAR-γ agonist...
Autores principales: | Parvin, Rehana, Noro, Erika, Saito-Hakoda, Akiko, Shimada, Hiroki, Suzuki, Susumu, Shimizu, Kyoko, Miyachi, Hiroyuki, Yokoyama, Atsushi, Sugawara, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937427/ https://www.ncbi.nlm.nih.gov/pubmed/29849538 http://dx.doi.org/10.1155/2018/5346272 |
Ejemplares similares
-
Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression
por: Saito-Hakoda, Akiko, et al.
Publicado: (2015) -
Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure
por: Suzuki, Dai, et al.
Publicado: (2017) -
Obesity and Hyperphagia With Increased Defective ACTH: A Novel POMC Variant
por: van der Valk, Eline S, et al.
Publicado: (2022) -
High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells
por: Shimada, Hiroki, et al.
Publicado: (2017) -
Induction of Integral Membrane PAM Expression in AtT-20 Cells Alters the Storage and Trafficking of POMC and PC1
por: Ciccotosto, Giuseppe D., et al.
Publicado: (1999)